Swedish Orphan Biovitrum AB (BIOVF)
Swedish Orphan Biovitrum Market Cap : 16.42B for May 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BONESUPPORT HOLDING AB | 1.656B |
| BioInvent International AB | 216.40M |
| Hansa Biopharma AB | 289.23M |
| BioArctic AB | 3.075B |
| Egetis Therapeutics AB | 293.40M |
Market Cap Related Metrics
| PE Ratio | 165.02 |
| PS Ratio | 5.367 |
| Price to Book Value | 3.874 |
| Price to Free Cash Flow | 36.09 |
| Price | 47.48 |
| Earnings Yield | 0.61% |
| Operating PE Ratio | 18.06 |
| Normalized PE Ratio | 26.08 |